Real-time enrollment status for this fatty liver disease clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT06318169 |
| Recruiting Status | Recruiting |
| Condition | Fatty Liver Disease |
| Phase | PHASE3 |
| Target Enrollment | 1,350 participants |
| Active Locations | 154 sites in the US |
| Sponsor | 89bio, Inc. |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 15, 2026: Clinical trial NCT06318169 is currently recruiting participants. This phase3 study for fatty liver disease is actively seeking new participants at 154 locations across the United States. The study is sponsored by 89bio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06318169 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 154 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06318169 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.